Heterocyclic compounds and methods of use thereof
Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Hocker Michael D Holladay Mark W Rowbottom Martin W Xu Shimin Liu Gang Hadd Michael J |
| description | Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9938261B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9938261B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9938261B23</originalsourceid><addsrcrecordid>eNrjZDD0SC1JLcpPrkzOyUxWSM7PLcgvzUspVkjMS1HITS3JyAey89MUSotTFUoyUotS89N4GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakl8aLClpbGFkZmhk5ExEUoAWZ0rog</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Heterocyclic compounds and methods of use thereof</title><source>esp@cenet</source><creator>Hocker Michael D ; Holladay Mark W ; Rowbottom Martin W ; Xu Shimin ; Liu Gang ; Hadd Michael J</creator><creatorcontrib>Hocker Michael D ; Holladay Mark W ; Rowbottom Martin W ; Xu Shimin ; Liu Gang ; Hadd Michael J</creatorcontrib><description>Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180410&DB=EPODOC&CC=US&NR=9938261B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180410&DB=EPODOC&CC=US&NR=9938261B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Hocker Michael D</creatorcontrib><creatorcontrib>Holladay Mark W</creatorcontrib><creatorcontrib>Rowbottom Martin W</creatorcontrib><creatorcontrib>Xu Shimin</creatorcontrib><creatorcontrib>Liu Gang</creatorcontrib><creatorcontrib>Hadd Michael J</creatorcontrib><title>Heterocyclic compounds and methods of use thereof</title><description>Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD0SC1JLcpPrkzOyUxWSM7PLcgvzUspVkjMS1HITS3JyAey89MUSotTFUoyUotS89N4GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakl8aLClpbGFkZmhk5ExEUoAWZ0rog</recordid><startdate>20180410</startdate><enddate>20180410</enddate><creator>Hocker Michael D</creator><creator>Holladay Mark W</creator><creator>Rowbottom Martin W</creator><creator>Xu Shimin</creator><creator>Liu Gang</creator><creator>Hadd Michael J</creator><scope>EVB</scope></search><sort><creationdate>20180410</creationdate><title>Heterocyclic compounds and methods of use thereof</title><author>Hocker Michael D ; Holladay Mark W ; Rowbottom Martin W ; Xu Shimin ; Liu Gang ; Hadd Michael J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9938261B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Hocker Michael D</creatorcontrib><creatorcontrib>Holladay Mark W</creatorcontrib><creatorcontrib>Rowbottom Martin W</creatorcontrib><creatorcontrib>Xu Shimin</creatorcontrib><creatorcontrib>Liu Gang</creatorcontrib><creatorcontrib>Hadd Michael J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Hocker Michael D</au><au>Holladay Mark W</au><au>Rowbottom Martin W</au><au>Xu Shimin</au><au>Liu Gang</au><au>Hadd Michael J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Heterocyclic compounds and methods of use thereof</title><date>2018-04-10</date><risdate>2018</risdate><abstract>Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US9938261B2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Heterocyclic compounds and methods of use thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A35%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Hocker%20Michael%20D&rft.date=2018-04-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9938261B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |